PF-07915234
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 10
Of
10
Go to page
1
February 05, 2026
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=485 | Terminated | Sponsor: Pfizer | N=900 ➔ 485 | Trial completion date: Aug 2030 ➔ Sep 2025 | Active, not recruiting ➔ Terminated | Trial primary completion date: Feb 2026 ➔ Sep 2025; Strategic decision made by the company
Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Herpes Zoster • Infectious Disease • Varicella Zoster
October 17, 2025
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Recruiting | Sponsor: Pfizer | Active, not recruiting ➔ Recruiting
Enrollment open • Herpes Zoster • Infectious Disease • Varicella Zoster
April 15, 2025
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Active, not recruiting | Sponsor: Pfizer | Trial completion date: May 2030 ➔ Aug 2030 | Trial primary completion date: Nov 2025 ➔ Feb 2026
Trial completion date • Trial primary completion date • Herpes Zoster • Infectious Disease • Varicella Zoster
September 21, 2024
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed • Herpes Zoster • Infectious Disease • Varicella Zoster
December 06, 2023
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Recruiting | Sponsor: Pfizer | Phase classification: P1/2 ➔ P2
Phase classification • Herpes Zoster • Infectious Disease • Varicella Zoster
September 18, 2023
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=900 | Recruiting | Sponsor: Pfizer | Phase classification: P2 ➔ P1/2
Phase classification • Herpes Zoster • Infectious Disease • Varicella Zoster
June 29, 2023
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Recruiting | Sponsor: Pfizer | Trial completion date: Jan 2030 ➔ Aug 2030 | Trial primary completion date: Jul 2025 ➔ Feb 2026
Trial completion date • Trial primary completion date • Herpes Zoster • Infectious Disease • Varicella Zoster
March 03, 2023
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Recruiting | Sponsor: Pfizer | Trial primary completion date: Mar 2028 ➔ Jul 2025
Trial primary completion date • Herpes Zoster • Infectious Disease • Varicella Zoster
February 08, 2023
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Herpes Zoster • Infectious Disease • Varicella Zoster
January 30, 2023
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
(clinicaltrials.gov)
- P2 | N=900 | Not yet recruiting | Sponsor: Pfizer
New P2 trial • Herpes Zoster • Infectious Disease • Varicella Zoster
1 to 10
Of
10
Go to page
1